# EDGAR Filing Document

**Accession Number:** 0001917375
**File Stem:** 0001104659-23-033229
**Filing Date:** 2023-3
**Character Count:** 1483
**Document Hash:** 6ec9395ca397128009ea1613816d69f5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-033229.hdr.sgml**: 20230418

**ACCESSION NUMBER**: 0001104659-23-033229

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ONCOLYZE, INC.
- **CENTRAL INDEX KEY:** 0001917375
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 845 UN PLAZA, APT. 61B
- **STREET 2:** ATTN: STEVEN J. EVANS, M.D.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 917-670-5933

**MAIL ADDRESS:**
- **STREET 1:** 845 UN PLAZA, APT. 61B
- **STREET 2:** ATTN: STEVEN J. EVANS, M.D.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

Office of Life Sciences

Division of Corporation Finance

Securities and Exchange Commission Washington, DC 20549

March 16, 2023

Re: Oncolyze, Inc.

**Post-Qualification Amendment to Offering Statement on Form 1-A**

**File No. 024-11890**

Ladies and Gentlemen:

On behalf of Oncolyze, Inc., I hereby request qualification of the above-referenced offering statement at 2:00 P.M., Eastern Time, on Monday, March 20, 2023, or as soon thereafter as is practicable.

Sincerely,

/s/ Steven J. Evans

Steven J. Evans

Chief Executive Officer

Oncolyze, Inc.

Cc: Jeanne Campanelli

CrowdCheck Law LLP